HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone​," but experts say concerns ...

An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

As the Food and Drug Administration undertakes a full agency review of the safety of the chemical abortion drug mifepristone, four pro-abortion attorneys general are asking the FDA to reverse course ...

The FDA has already lifted several restrictions on mifepristone over the last decade. In 2016, it extended the window in which mifepristone could be used to terminate pregnancies from seven weeks ...

Mifepristone, which is taken with a second drug, misoprostol, to end an early pregnancy, was first approved by the FDA in 2000 after "a thorough and comprehensive review" determined it was safe ...

California joined Massachusetts, New York and New Jersey in asking the FDA to ease restrictions on the abortion pill, or exempt them from those restrictions. Health and Human Services Secretary ...

(The Center Square) – On the three-year anniversary of the U.S. Supreme Court overturning Roe v Wade, dozens of state ...

Four Democrat-led states ask FDA to remove abortion pill restrictions. The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on ...

Food and Drug Administration (FDA) Commissioner Marty Makary committed to reviewing the abortion drug mifepristone in a letter sent to Sen. Josh Hawley (R-Mo.). “As with all drugs, FDA continues ...